We then analyzed the selective dependency on EP300 and CREBBP of a series of leukemia compared to other tumor cells in DepMap database, highlighting EP300/CREBBP potential targeting in AML cells (Additional file 1: Figure S1A). This evidence concerns the gene EP300 and acute myeloid leukemia.